Molbio Diagnostics IPO is scheduled to list on 17 Aug 2026 on BSE, NSE.
Listed
Mainboard IPO
MOLBIO
Molbio Diagnostics IPO Listing Price Today
Molbio Diagnostics IPO listed on 17 Aug 2026 at ₹980 against an issue price of ₹807, a listing gain of +21.44%.
- Issue price
- ₹807
- Actual listing price
- ₹980
- Listing Date
- 17 Aug 2026
- Exchange
- BSE, NSE
Live share price
Molbio Diagnostics share price
-
vs issue price
Open-
Day high-
Day low-
Exchange-
Loading live price…
The live price isn't available right now. Check back shortly.
Source: Yahoo Finance. Prices may be delayed by a few minutes.
GMP vs actual
Molbio Diagnostics listing price vs GMP estimate
| Issue price | ₹807 |
|---|---|
| Latest GMP | ₹120 (+14.87%) |
| Expected listing price (issue price + GMP) | ₹927 |
| Actual listing price | ₹980 |
| Listing gain | +21.44% |
| Difference from GMP estimate | +₹53 (+5.72%) |
Profit per application
₹3,114
At the listing price, for 18 shares
GMP is an unofficial grey market indicator, not a guarantee of the listing price.
Empirical GMP Accuracy:
Across 117 Indian IPOs, positive GMP predicted positive listing gains 69.8% of the time (72.2% of Mainboard IPOs opened within 10% of their GMP estimate).
View Research Report →
GMP trend
Molbio Diagnostics GMP trend before listing
| Date | GMP | Change |
|---|---|---|
| 12 Aug 2026 | ₹138.00 | +6 |
| 10 Aug 2026 | ₹132.00 | - |
Listing day
Listing day timings
| Listing Date | 17 Aug 2026 |
|---|---|
| Special pre-open session | 9:00 AM - 9:45 AM |
| Normal trading starts | 10:00 AM |
| Exchange | BSE, NSE |
FAQ
Molbio Diagnostics IPO: frequently asked questions
Molbio Diagnostics IPO listed at ₹980 against an issue price of ₹807, a listing gain of +21.44%.
On listing day, a special pre-open session runs from 9:00 AM to 9:45 AM to set the listing price. Molbio Diagnostics shares then start normal trading at 10:00 AM.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
At the listing price, one minimum application of 18 shares in Molbio Diagnostics IPO made about ₹3,114.